RNCOS Releases a New Report - Booming Clinical Trials Market in India

RNCOS has recently added a new Market Research Report titled, "flourishing Clinical Trials Market in India" to its report gallery. The clinical trials in India looks very lucrative. The country is expected to be one of the hottest destinations for conducting global clinical trials due to a huge patient pool, representing both chronic and infectious diseases, easy recruitment of patients and significant savings. Moreover, the market will boost from improved protection of intellectual property rights with modified rules and also from reduced taxes.

According to our new research study on the sector called "boomer Clinical Trials Market in India", the clinical trials outsourced market in India is forecasted to grow at a CAGR of around 31% in 2010-2012. Currently, the market is characterized by the dominance of Phase III and Phase II trials, which currently has more than 80% of the market. This scenario is expected to remain intact in the future. In terms of competitive landscape, the market is characterized by many small Cros, with some companies who sings, Quintiles, Oxygen therapy, Vita labs perform better relative to the rest.

Our report has found that one of the biggest causes attract pharmaceutical manufacturers and cross into India, the country's huge patient pool. The number of patients in chronic and infectious diseases in India exceeds that almost any other country. Furthermore, clinical trials of drugs related to the central nervous system and cancer has been largely outsourced to India in recent years. Backed by this factor, the number of clinical trials in India is expected to grow at a CAGR of over 14% over the forecast period. In this context, the report, the rational analysis of the factors underpinning the forecast.

Our report provides comprehensive information on clinical trials market in India, with detailed description of the regulatory environment and cost factors to promote the market. It also highlights some new trends in the market as clinical data management, pathology and diagnostic market, etc. research study offers detailed statistical and analytical review on demographics, macroeconomic indicators, disease profile, clinical services market, key drivers and restraints. It contains all the necessary information that can help clients to develop market strategies and assess opportunity areas in the Indian clinical trials market.